Torthaí cuardaigh - James Suh

Beachtaigh na torthaí
  1. 1
    Prevalence of established and emerging biomarkers of immune checkpoint inhibitor response in advanced hepatocellular carcinoma

    Prevalence of established and emerging biomarkers of immune checkpoint inhibitor response in advanced hepatocellular carcinoma de réir Celina Ang, Samuel J. Klempner, Siraj M. Ali, Russell W. Madison, Jeffrey S. Ross, Eric A. Severson, David Fabrizio, Aaron M. Goodman, Razelle Kurzrock, James Suh, Sherri Z. Millis

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Genomic characterization of thymic epithelial tumors in a real-world dataset

    Genomic characterization of thymic epithelial tumors in a real-world dataset de réir Ken Kurokawa, Takehito Shukuya, R.A. Greenstein, Bünyamin Kaplan, Heather A. Wakelee, Jeffrey S. Ross, Katsuyuki Miura, Kazuyuki Furuta, Shumei Kato, James Suh, Smruthy Sivakumar, Ethan Sokol, David P. Carbone, Kazuhisa Takahashi

    Foilsithe / Cruthaithe 2023
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Pulmonary Pathologic Findings of Fatal 2009 Pandemic Influenza A/H1N1 Viral Infections

    Pulmonary Pathologic Findings of Fatal 2009 Pandemic Influenza A/H1N1 Viral Infections de réir James R. Gill, Zong‐Mei Sheng, Susan F. Ely, Donald G. Guinee, Mary Beth Beasley, James Suh, Charuhas Deshpande, Daniel J. Mollura, David M. Morens, Mike Bray, William D. Travis, Jeffery K. Taubenberger

    Foilsithe / Cruthaithe 2010
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Comprehensive Genomic Profiling Facilitates Implementation of the National Comprehensive Cancer Network Guidelines for Lung Cancer Biomarker Testing and Identifies Patients Who May Benefit From Enrollment in Mechanism-Driven Clinical Trials

    Comprehensive Genomic Profiling Facilitates Implementation of the National Comprehensive Cancer Network Guidelines for Lung Cancer Biomarker Testing and Identifies Patients Who May... de réir James Suh, Adrienne Johnson, Lee A. Albacker, Kai Wang, Juliann Chmielecki, Garrett M. Frampton, Laurie M. Gay, Julia A. Elvin, Jo‐Anne Vergilio, Siraj M. Ali, Vincent A. Miller, Philip J. Stephens, Jeffrey S. Ross

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    High-Throughput Genomic Profiling of Adult Solid Tumors Reveals Novel Insights into Cancer Pathogenesis

    High-Throughput Genomic Profiling of Adult Solid Tumors Reveals Novel Insights into Cancer Pathogenesis de réir Ryan J. Hartmaier, Lee A. Albacker, Juliann Chmielecki, Mark Bailey, Jie He, Michael E. Goldberg, Shakti Ramkissoon, James Suh, Julia A. Elvin, Samuel Chiacchia, Garrett M. Frampton, Jeffrey S. Ross, Vincent A. Miller, Philip J. Stephens, Doron Lipson

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Nonamplification <i>ERBB2</i> genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti‐HER2 targeted therapies

    Nonamplification <i>ERBB2</i> genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti‐HER2 targeted therapies de réir Jeffrey S. Ross, Laurie M. Gay, Kai Wang, Siraj M. Ali, Saranya Chumsri, Julia A. Elvin, Ron Bose, Jo‐Anne Vergilio, James Suh, Roman Yelensky, Doron Lipson, Juliann Chmielecki, Stanley E. Waintraub, Brian Leyland‐Jones, Vincent A. Miller, Philip J. Stephens

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    HER2 V659 and G660 transmembrane mutations that stabilize homo- and hetero-dimerization are rare oncogenic drivers in lung adenocarcinoma that are clinically responsive to afatinib

    HER2 V659 and G660 transmembrane mutations that stabilize homo- and hetero-dimerization are rare oncogenic drivers in lung adenocarcinoma that are clinically responsive to afatinib de réir S.-H.I. Ou, Alexa B. Schrock, Eduard V. Bocharov, Samuel J. Klempner, Charbel Haddad, Gary Steinecker, Melissa L. Johnson, Barbara J. Gitlitz, Jon Chung, Paulo Vidal Campregher, J.S. Ross, P. Stephens, V.A. Miller, James Suh, Siraj M. Ali, Vamsidhar Velcheti

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    Comprehensive genomic profiling of different subtypes of nasopharyngeal carcinoma reveals similarities and differences to guide targeted therapy

    Comprehensive genomic profiling of different subtypes of nasopharyngeal carcinoma reveals similarities and differences to guide targeted therapy de réir Siraj M. Ali, Ming Yao, Jicheng Yao, Jing Wang, Yu‐Wei Cheng, Alexa B. Schrock, Gung‐Wei Chirn, Hui Chen, Shuo Mu, Laurie M. Gay, Julia A. Elvin, James Suh, Vincent A. Miller, Philip J. Stephens, Jeffrey S. Ross, Kai Wang

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in <i>ERBB2</i> and <i>ERBB3</i>

    Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in <i>ERBB2</i> and <i>ERBB3</i> de réir Jeffrey S. Ross, Marwan Fakih, Siraj M. Ali, Julia A. Elvin, Alexa B. Schrock, James Suh, Jo‐Anne Vergilio, Shakti Ramkissoon, Eric A. Severson, Sugganth Daniel, David Fabrizio, Garrett M. Frampton, James Sun, Vincent A. Miller, Philip J. Stephens, Laurie M. Gay

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    Comprehensive Genomic Profiling of Esthesioneuroblastoma Reveals Additional Treatment Options

    Comprehensive Genomic Profiling of Esthesioneuroblastoma Reveals Additional Treatment Options de réir Laurie M. Gay, Sungeun Kim, Kyle Fedorchak, Madappa N. Kundranda, Yazmín Odia, Chaitali Nangia, James Battiste, Gerardo Colón‐Otero, Steven Powell, Jeffery S. Russell, Julia A. Elvin, Jo-Anne Vergilio, James Suh, Siraj M. Ali, Philip J. Stephens, Vincent A. Miller, Jeffrey S. Ross

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as Biomarkers

    Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as Biomarkers de réir Aatur D. Singhi, Ben George, Joel Greenbowe, Jon Chung, James Suh, Anirban Maitra, Samuel J. Klempner, Andrew Hendifar, Javle Milind, Talia Golan, Randall E. Brand, Amer H. Zureikat, Somak Roy, Alexa B. Schrock, Vincent A. Miller, Jeffrey S. Ross, Siraj M. Ali, Nathan Bahary

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    HER2 Transmembrane Domain (TMD) Mutations (V659/G660) That Stabilize Homo- and Heterodimerization Are Rare Oncogenic Drivers in Lung Adenocarcinoma That Respond to Afatinib

    HER2 Transmembrane Domain (TMD) Mutations (V659/G660) That Stabilize Homo- and Heterodimerization Are Rare Oncogenic Drivers in Lung Adenocarcinoma That Respond to Afatinib de réir Sai‐Hong Ignatius Ou, Alexa B. Schrock, Eduard V. Bocharov, Samuel J. Klempner, Carolina Kawamura Haddad, Gary Steinecker, Melissa L. Johnson, Barbara J. Gitlitz, Jon Chung, Paulo Vidal Campregher, Jeffrey S. Ross, Philip J. Stephens, Vincent A. Miller, James Suh, Siraj M. Ali, Vamsidhar Velcheti

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    Comprehensive genomic profiles of metastatic and relapsed salivary gland carcinomas are associated with tumor type and reveal new routes to targeted therapies

    Comprehensive genomic profiles of metastatic and relapsed salivary gland carcinomas are associated with tumor type and reveal new routes to targeted therapies de réir Jeffrey S. Ross, Laurie M. Gay, K. Wang, Jo‐Anne Vergilio, James Suh, Shakti Ramkissoon, Hilary Somerset, Jennifer M. Johnson, Jeffery S. Russell, Siraj M. Ali, Alexa B. Schrock, David Fabrizio, Garrett M. Frampton, V.A. Miller, Philip J. Stephens, Julia A. Elvin, Daniel W. Bowles

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    Characterization of 298 Patients with Lung Cancer Harboring MET Exon 14 Skipping Alterations

    Characterization of 298 Patients with Lung Cancer Harboring MET Exon 14 Skipping Alterations de réir Alexa B. Schrock, Garrett M. Frampton, James Suh, Zachary R. Chalmers, Mark R. Rosenzweig, Rachel Erlich, Balázs Halmos, Jonathan W. Goldman, Patrick M. Forde, Kurt Leuenberger, Nir Peled, Gregory P. Kalemkerian, Jeffrey S. Ross, Philip J. Stephens, Vincent A. Miller, Siraj M. Ali, Sai‐Hong Ignatius Ou

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    Inactivation of Capicua drives cancer metastasis

    Inactivation of Capicua drives cancer metastasis de réir Ross A. Okimoto, Frank Breitenbuecher, Victor Olivas, Wei Wu, Beatrice Gini, Matan Hofree, Saurabh Asthana, Gorjan Hrustanovic, Jennifer C. Flanagan, Asmin Tulpule, Collin M. Blakely, Henry J. Haringsma, Andrew D. Simmons, Kyle Gowen, James Suh, Vincent A. Miller, Siraj M. Ali, Martin Schüler, Trever G. Bivona

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 16
    Evaluation of 122 advanced-stage cutaneous squamous cell carcinomas by comprehensive genomic profiling opens the door for new routes to targeted therapies

    Evaluation of 122 advanced-stage cutaneous squamous cell carcinomas by comprehensive genomic profiling opens the door for new routes to targeted therapies de réir Rami N. Al‐Rohil, Ashley J. Tarasen, J. Andrew Carlson, Kai Wang, Adrienne Johnson, Roman Yelensky, Doron Lipson, Julia A. Elvin, Jo‐Anne Vergilio, Siraj M. Ali, James Suh, Vincent A. Miller, Philip J. Stephens, Prasanth Ganesan, Filip Janků, Daniel D. Karp, Vivek Subbiah, Martín C. Mihm, Jeffrey S. Ross

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 17
    <i>ALK</i>Fusions in a Wide Variety of Tumor Types Respond to Anti-ALK Targeted Therapy

    <i>ALK</i>Fusions in a Wide Variety of Tumor Types Respond to Anti-ALK Targeted Therapy de réir Jeffrey S. Ross, Siraj M. Ali, Omotayo Fasan, Jared Block, Sumanta K. Pal, Julia A. Elvin, Alexa B. Schrock, James Suh, Sahar Nozad, Sungeun Kim, Hwajeong Lee, Christine E. Sheehan, David Jones, Jo‐Anne Vergilio, Shakti Ramkissoon, Eric A. Severson, Sugganth Daniel, David Fabrizio, Garrett M. Frampton, V. A. Miller, Philip J. Stephens, Laurie M. Gay

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  18. 18
    Comprehensive genomic profiling of anal squamous cell carcinoma reveals distinct genomically defined classes

    Comprehensive genomic profiling of anal squamous cell carcinoma reveals distinct genomically defined classes de réir Jon Chung, Eric M. Sanford, Adrienne Johnson, Samuel J. Klempner, Alexa B. Schrock, Norma Alonzo Palma, Rachel Erlich, Garrett M. Frampton, Zachary R. Chalmers, Jo‐Anne Vergilio, Douglas A. Rubinson, Jiayi Sun, Juliann Chmielecki, Roman Yelensky, James Suh, Doron Lipson, Thomas J. George, Julia A. Elvin, Philip J. Stephens, V.A. Miller, Jeffrey S. Ross, Siraj M. Ali

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  19. 19
    Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic Profiling

    Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic Profiling de réir Alexa B. Schrock, Shuyu Dan Li, Garrett M. Frampton, James Suh, Eduardo Braun, Ranee Mehra, Steven C. Buck, José A. Bufill, Nir Peled, Nagla Abdel Karim, Kuang-Yang Hsieh, Manuel I. Doria, James A. Knost, Rong Chen, Sai‐Hong Ignatius Ou, Jeffrey S. Ross, Philip J. Stephens, Paul A. S. Fishkin, Vincent A. Miller, Siraj M. Ali, Balázs Halmos, Jane J. Liu

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  20. 20
    Genomic Profiling of a Large Set of Diverse Pediatric Cancers Identifies Known and Novel Mutations across Tumor Spectra

    Genomic Profiling of a Large Set of Diverse Pediatric Cancers Identifies Known and Novel Mutations across Tumor Spectra de réir Juliann Chmielecki, Mark Bailey, Jie He, Julia A. Elvin, Jo‐Anne Vergilio, Shakti Ramkissoon, James Suh, Garrett M. Frampton, James Sun, Samantha Morley, Daniel Spritz, Siraj M. Ali, Laurie M. Gay, Rachel Erlich, Jeffrey S. Ross, Joana Buxhaku, Hilary Davies‐Kershaw, Vinny Faso, Alexis Germain, Blair Glanville, Vincent A. Miller, Philip J. Stephens, Katherine A. Janeway, John M. Maris, Soheil Meshinchi, Trevor J. Pugh, Jack F. Shern, Doron Lipson

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: